indazoles has been researched along with HIV Coinfection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chao, W; Gu, CJ; Hadas, E; Kelschenbach, J; Kim, BH; Potash, MJ; Volsky, DJ | 1 |
Ahmadyar, S; Brass, AL; Chou, K; Cihlar, T; Gonik, D; Hansen, D; Hu, EY; Hung, M; Jin, D; Liclican, A; Link, JO; Lu, B; McDougall, WM; Mulato, A; Niedziela-Majka, A; Novikov, N; Paoli, E; Papalia, GA; Perreira, JM; Ram, RR; Schroeder, SD; Singer, E; Stepan, GJ; Sundquist, WI; Tse, WC; Wong, MH; Yant, SR; Yu, H; Zhang, JR; Zheng, J | 1 |
Freed, EO; Kleinpeter, AB | 1 |
1 review(s) available for indazoles and HIV Coinfection
Article | Year |
---|---|
HIV-1 Maturation: Lessons Learned from Inhibitors.
Topics: Anti-HIV Agents; Capsid; Capsid Proteins; Clinical Trials as Topic; Drug Resistance, Viral; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Indazoles; Protein Processing, Post-Translational; Pyridines; RNA, Viral; Succinates; Triterpenes; Viral Genome Packaging; Virus Assembly; Virus Replication | 2020 |
2 other study(ies) available for indazoles and HIV Coinfection
Article | Year |
---|---|
CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice.
Topics: AIDS Dementia Complex; Animals; Chemokine CCL2; Cognition; Disease Models, Animal; HIV Infections; Indazoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Receptors, CCR2 | 2023 |
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model.
Topics: Animals; Anti-HIV Agents; Capsid; Capsid Proteins; Delayed-Action Preparations; DNA, Viral; Drug Resistance, Viral; HIV Infections; HIV-1; HIV-2; Humans; Indazoles; Medication Adherence; Mice; Pyridines; Small Molecule Libraries | 2019 |